THE EFFECTIVENESS OF TREATMENT OF BRONCHIAL ASTHMA DURING PREGNANCY UNDER THE CONTROL OF THE LEVEL OF NITRIC OXIDE IN THE EXHALED AIR
In the study of pregnant women with asthma (BA), the level of nitric oxide in the exhaled air was determined in 100 women with different levels of the disease control. The average disease duration was 8.84 ± 0.75 years. We studied the level of nitric oxide in the exhaled air using the NO Breath apparatus (Great Britain) in each trimester of pregnancy and with exacerbation of asthma. The inverse relationship between adherence to treatment at different gestational periods and the level of NOex was determined. In pregnant women with moderate and severe ВА, with constant administration of IHC, a significant decrease in nitric oxide level was observed; therefore, they had fewer exacerbations of ВА and achievement of control over asthma. According to our data, the constant intake of IHC significantly reduced the level of NOex in BAMC and BASC, that reduced the number of exacerbations of ВА during pregnancy